MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis

A Ghoochani1, M A Schwarz1, E Yakubov1

  • 1Department of Neurosurgery, Universitätsklinikum Erlangen, Medical Faculty of the Friedrich Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.

Oncogene
|May 10, 2016
PubMed

Insights

Brain tumors hijack microglia, promoting glioma growth by blocking immune surveillance. Inhibiting MIF-CD74 signaling restores microglial M1 function and interferon-gamma, enhancing anti-tumor immunity and survival.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cell Biology

Background:

  • Microglia within the brain tumor microenvironment exacerbate glioma malignancy.
  • Microglia adopt an immunosuppressive M2 phenotype, fostering glioma progression and evading immune surveillance.

Purpose of the Study:

  • To investigate mechanisms by which gliomas abolish immune surveillance.
  • To identify therapeutic targets for restoring anti-tumor immune responses in the glioma microenvironment.

Main Methods:

  • Investigated the role of macrophage migration inhibitory factor (MIF) and CD74 signaling in microglia polarization.
  • Utilized antibody neutralization and small interfering RNA (siRNA) to inhibit MIF-CD74 interactions.
  • Assessed changes in microglial M1/M2 states, interferon-gamma (IFN-γ) secretion, and ERK1/2 phosphorylation.
  • Evaluated therapeutic efficacy in glioma-implanted mouse models.

Main Results:

  • Glioma cells secrete MIF, activating microglial CD74 and inducing an immunosuppressive M2 shift, thereby inhibiting pro-inflammatory M1 conversion.
  • Inhibition of MIF-CD74 signaling reinstated microglial M1 function and IFN-γ secretion.
  • IFN-γ release directly inhibited glioma growth and promoted a M2 to M1 shift in microglia.
  • Interfering with MIF-CD74 signaling prolonged survival in glioma-bearing mice.

Conclusions:

  • The MIF-CD74 pathway is crucial for glioma-induced immune suppression by microglia.
  • Targeting MIF-CD74 signaling offers a therapeutic strategy to restore IFN-γ-mediated anti-tumor immunity.
  • Restoring microglial pro-inflammatory function is a viable approach for glioma treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K